Treatment of patients having c-met exon 14 skipping mutations
US12215160B2 · kind B2 · utility
0Cited by
24References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2021 |
| Grant date | Feb 4, 2025 |
| Priority date | — |
| Expiry date | Jul 2, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to treatment of subjects having a cancer that is positive for c-Met exon 14 skipping mutations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.